201014
N-Benzylbenzamide
≥98%
Sinónimos:
Benzoic acid benzylamide, N-(Phenylmethyl)benzamide, N-Benzoylbenzylamine
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula lineal:
C6H5CONHCH2C6H5
Número CAS:
Peso molecular:
211.26
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
216-063-4
MDL number:
Assay:
≥98%
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Segment
assay
≥98%
mp
104-106 °C (lit.)
solubility
acetone: 25 mg/mL, clear, colorless
functional group
amide, phenyl
SMILES string
O=C(NCc1ccccc1)c2ccccc2
InChI
1S/C14H13NO/c16-14(13-9-5-2-6-10-13)15-11-12-7-3-1-4-8-12/h1-10H,11H2,(H,15,16)
InChI key
LKQUCICFTHBFAL-UHFFFAOYSA-N
General description
N-Benzylbenzamide inhibits the activity of tyrosinase.
Application
A convenient precursor to α-substituted benzylamines and an indicator for the titration of butyllithium and other lithium bases. For references see Aldrichimica Acta .
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Manting Chiang et al.
Pharmaceutical research, 37(10), 205-205 (2020-09-30)
Modulation of 5-HT3 receptor in the central nervous system (CNS) is a promising approach for treatment of neuropathic pain. The goal was to evaluate the role of P-glycoprotein (Pgp) in limiting exposure of different parts of the CNS to ondansetron
Yae Eun Chong et al.
Biomedical chromatography : BMC, 33(11), e4653-e4653 (2019-07-20)
Ondansetron, a widely used antiemetic agent, is a P-glycoprotein (P-gp) substrate and therefore expression of P-gp at the blood-brain barrier limits its distribution to the central nervous system (CNS), which was observed to be reversed by coadministration with P-gp inhibitors.
Sung Jin Cho et al.
Bioorganic & medicinal chemistry letters, 16(10), 2682-2684 (2006-03-04)
A series of potent inhibitors of tyrosinase and their structure-activity relationships are described. N-Benzylbenzamide derivatives (1-21) with hydroxyl(s) were synthesized and tested for their tyrosinase inhibitory activity. With this series, compound 15 provided a potent tyrosinase inhibition: it effectively inhibited
Número de artículo de comercio global
| SKU | GTIN |
|---|---|
| 201014-5G | 04061831828825 |